Women's experiences of the final stage of early medical abortion at home: results of a pilot survey
Open Access
- 1 October 2010
- journal article
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 36 (4), 213-216
- https://doi.org/10.1783/147118910793048719
Abstract
Background and methodology Research has shown that many women choosing an early medical abortion would prefer to be at home rather than in hospital to expel the pregnancy. A service was commenced at a hospital abortion service in Edinburgh, Scotland, UK that allowed women at up to 56 days9 gestation to be discharged home soon after misoprostol administration. During a 3-month period, an anonymous questionnaire of women9s experiences was conducted 1—2 weeks after the procedure. Results During the 3 months of the survey a total of 145 women chose to go home to abort. A total of 100 women completed questionnaires out of 145 (69%) distributed. The commonest reasons given for choosing to go home were: to get home sooner (53%) and to be in the privacy of one9s own home (47%). Most (81%) of the women stated that bleeding was either “as expected” (55%) or “not as bad as expected” (26%), and 58% of the women stated that the pain was “as expected” (40%) or “not as bad as expected” (18%). The majority (84%) of the women said that they would recommend this method to a friend. Discussion and conclusions Discharge home for the final stage of a medical abortion was highly acceptable to women. Since availability is not limited by hospital bed space, more women can be treated by medical methods.This publication has 8 references indexed in Scilit:
- Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 daysHuman Reproduction, 2010
- Women's opinions on the home management of early medical abortion in the UKBMJ Sexual & Reproductive Health, 2010
- Women's preferences for method of abortion and management of miscarriageBMJ Sexual & Reproductive Health, 2009
- Home abortion implies radical changes for womenThe European Journal of Contraception & Reproductive Health Care, 2009
- Setting up an outpatient service for early medical terminationBMJ Sexual & Reproductive Health, 2007
- Home use of two doses of misoprostol after mifepristone for medical abortion: A pilot study in Sweden and FranceThe European Journal of Contraception & Reproductive Health Care, 2005
- Acceptability of home-use of misoprostol in medical abortionContraception, 2004
- Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of EdinburghBJOG: An International Journal of Obstetrics and Gynaecology, 1996